Equities Analysts Offer Predictions for FDMT Q1 Earnings
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) – Analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of 4D Molecular Therapeutics in a report issued on Monday, March 3rd. HC Wainwright analyst M. Caufield anticipates that the company will earn ($0.92) per share for the quarter. HC Wainwright […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) – Analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of 4D Molecular Therapeutics in a report issued on Monday, March 3rd. HC Wainwright analyst M. Caufield anticipates that the company will earn ($0.92) per share for the quarter. HC Wainwright […]
